seo-company

Sonnet BioTherapeutics, Inc.

As experts in cytokine biology, our clinical stage pipeline comprises five cytokine-derived therapeutic candidates, with our lead proprietary compound, SON-1010, in Phase 1 development. Closely follow...load more


Sonnet BioTherapeutics, Inc.'s Basic Information

Industry
Headquarters
Princeton, Florida, United States
Founded Year
2011
Headcount
11 - 50 ( View All )
Specialties
Oncologyimmunotherapybiotherapeutics

Sonnet BioTherapeutics, Inc.'s Competitors

Ampal American Israel
Ampal American Israel

View all employees
Hong Kong Parkview Group Limited, THE
Hong Kong Parkview Group Limited, THE

View all employees
Biogen Pharmaceuticals
Biogen Pharmaceuticals

View all employees
Glory Biotech Corp.
Glory Biotech Corp.

South Korea

View all employees
Grey Innovation Group Pty Ltd
Grey Innovation Group Pty Ltd

Melbourne, Victoria, Australia

View all employees

Employee Insights

Employee Function
Employee Location

Sonnet BioTherapeutics, Inc.'s Top Employees

people

Pankaj Mohan

Founder & CEO

Phone Email

people

Richard Kenney, MD

Chief Medical Officer

Phone Email

Find Your Next Customer with Better Data

Get access to over 120 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd

GDPR compliantCancel anytime

Free credits every month!

Frequently Asked Questions Regarding Sonnet BioTherapeutics, Inc.

Where is Sonnet BioTherapeutics, Inc.'s headquarter located?
Sonnet BioTherapeutics, Inc.'s headquarter are located at United States.
How many employees does Sonnet BioTherapeutics, Inc. have?
Sonnet BioTherapeutics, Inc. has 11 - 50 employees.
What is Sonnet BioTherapeutics, Inc.'s official website?
Sonnet BioTherapeutics, Inc.'s official website is https://www.sonnetbio.com/news-media/press-releases
What does Sonnet BioTherapeutics, Inc. do?
As experts in cytokine biology, our clinical stage pipeline comprises five cytokine-derived therapeutic candidates, with our lead proprietary compound, SON-1010, in Phase 1 development. Closely follow...
What specialty does Sonnet BioTherapeutics, Inc. have?
Oncologyimmunotherapybiotherapeutics
Find Leads in 1 Click

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.

✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts